• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problems Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/01/2020
Event Type  Injury  
Manufacturer Narrative
Date of event was approximated as event date was not reported.
 
Event Description
It was reported that partial stent deployment occurred.Two 6x120x130 eluvia drug-eluting vascular stent systems were selected for a procedure in the popliteal artery, distal and mid superficial femoral artery (sfa).During the procedure, the stent was advanced contralaterally over a 0.035 bentson guidewire inside a 6fr non-boston scientific sheath to the target lesion.The lesion was pre dilated by a 5 mm mustang balloon.The first 6x120x130 eluvia stent deployed successfully in the popliteal artery.The second stent had difficulty to separate from delivery system which caused the stent to elongate.Then, the physician manually pulled the delivery system.The patient was taken to operating room and the stent was successfully removed by surgical intervention.The vascular surgeon determined that the stent was fully deployed but it was not placed properly.There were no patient complications and the patient's was doing great post-procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10791156
MDR Text Key214747476
Report Number2134265-2020-15262
Device Sequence Number1
Product Code NIU
UDI-Device Identifier08714729876618
UDI-Public08714729876618
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/10/2021
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0024324997
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/14/2020
Initial Date FDA Received11/05/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/15/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TERUMO - 6F DESTINATION SHEATH; UNKNOWN - 0.035 BENTSON GUIDEWIRE
Patient Outcome(s) Required Intervention;
-
-